Valuation: UCB

Market Cap 48.43B 55.41B 44.61B 41.38B 78.7B 5,286B 79.65B 533B 207B 2,594B 208B 204B 8,981B P/E 2026 *
27.4x
P/E 2027 * 21.6x
Enterprise Value 48.16B 55.1B 44.36B 41.15B 78.26B 5,257B 79.21B 530B 206B 2,579B 207B 202B 8,930B EV / Sales 2026 *
5.64x
EV / Sales 2027 * 4.79x
Free-Float
61.59%
Yield 2026 *
0.58%
Yield 2027 * 0.59%
1 day-1.97%
1 week-1.59%
Current month-2.90%
1 month-2.53%
3 months-3.82%
6 months+8.30%
Current year+6.62%
1 week 252.6
Extreme 252.6
268.3
1 month 243.3
Extreme 243.3
275.5
Current year 223
Extreme 223
289.5
1 year 165.1
Extreme 165.1
289.5
3 years 65.4
Extreme 65.4
289.5
5 years 65.4
Extreme 65.4
289.5
10 years 54.84
Extreme 54.84
289.5
Manager TitleAgeSince
Chief Executive Officer 67 01/01/2015
Director of Finance/CFO 59 01/07/2020
Chief Tech/Sci/R&D Officer 59 01/05/2024
Director TitleAgeSince
Director/Board Member 55 01/01/2012
Director/Board Member 67 01/01/2015
Director/Board Member 56 24/04/2014
Date Insider Type Main position Quantity % Market Cap.
01-15Buy

Director

500 0.0003%
01-15Fiscal year

Executive/Senior Manager

3,000 0.0015%
01-15Fiscal year

Executive/Senior Manager

3,000 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
-1.97%-1.59%+50.62%+218.16% 56.51B
-0.68%+2.67%+18.72%-9.48% 66.56B
-1.13%+40.50%+40.50%+40.50% 42.98B
+1.99%+8.15%-48.83%-54.69% 40.46B
-3.54%-3.50%+56.89%-27.08% 31.91B
+2.56%+21.60%+168.28%-33.79% 31.65B
-1.06%+1.64%+68.91%+83.55% 23.35B
+3.08%+20.43%+4.99%+186.85% 19.46B
+0.21%+2.96%+66.67%+129.01% 17.18B
+0.73%+10.69%+76.74%+344.54% 15.12B
Average -0.22%+9.25%+50.35%+87.76% 34.52B
Weighted average by Cap. -0.53%+7.82%+43.53%+64.61%

Financials

2026 *2027 *
Net sales 8.53B 9.76B 7.86B 7.29B 13.87B 932B 14.04B 93.95B 36.56B 457B 36.67B 35.86B 1,582B 9.63B 11.02B 8.88B 8.23B 15.66B 1,052B 15.85B 106B 41.28B 516B 41.4B 40.49B 1,787B
Net income 1.75B 2B 1.61B 1.49B 2.84B 191B 2.87B 19.24B 7.49B 93.58B 7.51B 7.34B 324B 2.26B 2.59B 2.09B 1.93B 3.68B 247B 3.72B 24.92B 9.7B 121B 9.73B 9.51B 420B
Net Debt -271M -310M -250M -232M -441M -29.61B -446M -2.99B -1.16B -14.53B -1.17B -1.14B -50.31B -2.31B -2.65B -2.13B -1.98B -3.76B -252B -3.8B -25.47B -9.91B -124B -9.94B -9.72B -429B
Logo UCB
UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.
Employees
9,765
Date Price Change Volume
06/07/26 €254.40 -1.97% 169,111
03/07/26 €259.50 -1.93% 131,923
02/07/26 €264.60 +2.60% 212,407
01/07/26 €257.90 -1.56% 217,639
30/06/26 €262.00 -0.57% 270,371
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
259.50EUR
Average target price
287.95EUR
Spread / Average Target
+10.96%

Quarterly revenue - Rate of surprise